CASP4 and neoplasm: In conclusion, in this study we propose the circulating and tumor-associated caspase-4 as a diagnostic biomarker for NSCLC that can be detected in both blood (in a non-invasive manner) and tissues with high sensitivity/true positive values compared to what so far described in the literature.